secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2025-03-04T23:59:59+00:00
Accession:  0001193125-25-045305
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics raises $15M in private placement; exchanges $3.2M in convertible notes
--------------------------------------------------------------------------------

- Private placement of ~28M shares (or prefunded warrants) at $0.66/unit, each with Series A and B warrants.
- Gross proceeds of ~$15M; includes exchange of $3.2M convertible notes for securities in the placement.
- Company repurchases $3.4M in notes and 3M warrants for $4.25M, eliminating financing restrictions.
- Believes it has regained compliance with Nasdaq minimum stockholders' equity requirement (Rule 5550(b)(1)).
- Closing contingent on Nasdaq confirmation by March 31, 2025; funds held in escrow pending.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525045305/0001193125-25-045305-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312525045305/d875007d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-045305

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer